MS
Patients/ Views & Analysis/ Views and analysis
Bridging the gap between pharma and the NHS in MS
mike.hammerton@pharmaphorum.com
Biogen, MS, multiple sclerosis, NHS
0 Comment
Patients/ Views & Analysis/ Views and analysis
Changing how we talk about clinical trials
mike.hammerton@pharmaphorum.com
clinical trials, MS, multiple sclerosis, patient insights
0 Comment
Sales and Marketing/ Views & Analysis/ Views and analysis
Is Tecfidera’s patent win a pyrrhic victory for Biogen?
George Underwood
aducanumab, Alzheimer's, Biogen, MS, Q4, Tecfidera
0 Comment
Patients/ Views & Analysis/ Views and analysis
Getting MS diagnosis right
George Underwood
MS, multiple sclerosis, patient insights, Trishna Bharadia
0 Comment
Patients/ Views & Analysis/ Views and analysis
Addressing MS’ two-tier healthcare system is about ‘social justice’
Amanda Barrell
MS, MS Trust, multiple sclerosis, Ocrevus
0 Comment
Digital/ Patients/ Views & Analysis/ Views & Analysis/ Views and analysis
Case study: Ensuring safety by digitally linking prescription management to blood monitoring
Amanda Barrell
blood monitoring, MS, MS Trust, QuDoS, QuDoS in MS
0 Comment
Articles/ Healthcare/ UK & Europe/ Views and analysis
‘Listen to your patients’: the best MS care honoured at QuDoS
Andrew McConaghie
MS, multiple sclerosis, QuDoS
0 Comment
Best healthcare professionals working in multiple sclerosis (MS) honoured QuDoS awards.
Articles/ Healthcare/ UK & Europe/ Views and analysis
5 questions: making Multiple Sclerosis care more patient-centric
Linda Banks
MS, multiple sclerosis, patient advocate, patient centricity, patient-centric, patients
0 Comment
Trishna Bharadia, Multiple Sclerosis patient advocate, wants to make MS care more patient-centric.